3rd Quarter - Amendment

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$940,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 16, 2014 $940,000 Replaced
3rd Quarter - Amendment (this page) Jan 5, 2016 $940,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Economics/Economic Development ECN

All provisions of HR2052 "Global Investment in American Jobs Act of 2013"

Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc.

LobbyistCovered position, as disclosed
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2052 (113th)

Animals ANI

Education and awareness of issues related to illegal compounding of veterinary drugs for animals; issues related to the veterinarian biologics National Environmental Policy Act (NEPA) exclusion.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Issues related to site infrastructure needs

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
PATRICK MAYES MCLAIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

General issues related to the 340B Federal Drug Pricing Program

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
SEAN CALLINICOS —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Corporate tax reform; all provisions of HR 4718 "To amend the Internal Revenue Code of 1986 to modify and make permanent bonus depreciation"; a strengthened and permanent U.S. R&D tax credit, including all such provisions in HR 4438 "American Research and Competitiveness Act of 2014", HR 3474 "Hire More Heroes Act of 2014", and HR4 "Jobs for America Act"; S2715 "Competitiveness and Opportunity by Modernizing and Permanently Extending the Tax Credit for Experimentation Act of 2014 or the COMPETE Act of 2014; tax policy issues related to corporate inversions including S2786 " Corporate Inverters Earnings Stripping Reform Act of 2014" and HR4679 & S2360 "Stop Corporate Inversions Act of 2014" and S2704 & HR5278 "No Federal Contracts for Corporate Deserters Act of 2014"; and all provisions of HR2835 and S 1647 "Restoring Access to Medication Act of 2013"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
SEAN CALLINICOS —
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2835 (113th), H.R. 5278 (113th), H.R. 4679 (113th), H.R. 4438 (113th), H.R. 3474 (113th), H.R. 4718 (113th), H.R. 4 (113th)

Copyright/Patent/Trademark CPT

International intellectual property issues; and all provisions of S 1720 "Patent Transparency and Improvements Act of 2013"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
SEAN CALLINICOS —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Education and awareness of the 2013-2014 influenza season; education and awareness of pandemic and biodefense funding, including policy ramifications of recent BARDA contract awards; education and awareness of Dengue; general issues related to FDA and NIH funding; all provisions of HR 2985 "Combination Drug Development Incentive Act of 2013"; education and awareness of diabetes and related treatment; and all provisions of HR 4502 "Stop Meth Labs and Enhance Patient Access Act of 2014"; continued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; all provisions of HR351 and S351 "Protecting Seniors' Access to Medicare Act of 2013"; general issues related to health care reform; and all general issues related to the 21st Century Cures Initiative.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
SEAN CALLINICOS —
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2985 (113th), H.R. 351 (113th), H.R. 4502 (113th)

Medicare/Medicaid MMM

Issues related to the Medicaid drug rebate policy; issues related to Medicare Part B Reimbursement of prescription drugs; issues related to Medication Therapy Management; and general issues related to the Medicare Part D Program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
SEAN CALLINICOS —
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Affiliated organisations

OrganisationLocation
SANOFI PASTEUR Swiftwater, PA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.